Page last updated: 2024-10-30

leflunomide and Cardiac Cancer

leflunomide has been researched along with Cardiac Cancer in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
" We report a 67-year-old woman with a 30-year history of rheumatoid arthritis, who had received treatment with leflunomide for 10 years and infliximab for 2 years."3.83Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist. ( Ameur, F; Benzerdjeb, N; Ikoli, JF; Sevestre, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benzerdjeb, N1
Ameur, F1
Ikoli, JF1
Sevestre, H1

Other Studies

1 other study available for leflunomide and Cardiac Cancer

ArticleYear
Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist.
    Pathology, research and practice, 2016, Volume: 212, Issue:12

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Felty Syndrome; Female; Heart Neoplasms; Humans;

2016